SANUWAVE Health Inc. logo

SANUWAVE Health Inc.

SNWV | NASDAQ
Chart Builder DCF Calculator
$4.64
+$0.20 (+4.50%)
At close: Sep 22, 2026, 4:00 PM ET
$4.64
$0 (0.00%)
After-hours: Sep 22, 2026, 4:10 PM ET

Market Data

Market Cap
$38.18M
Enterprise Value
$35.93M
Beta
1.46
Average Volume
169.76K
Shares Outstanding (Diluted)
8.6M
Shares Change YoY
-6.18%
Institutional Ownership
48.42%
Exchange
NASDAQ
ISIN
US80303D3052

Price Performance

Price Change 1M
-6.9%
Price Change 3M
-45.9%
Price Change 6M
-77.7%
Price Change YTD
-84.6%
Price Change 1Y
-87.4%
Price Change 3Y
-42.3%
Price Change 5Y
-89.2%
1M CAGR (ann.)
-24.5%
1Y CAGR (ann.)
-87.3%
5Y CAGR (ann.)
-34.7%
All-Time CAGR
-30.1%

Valuation

PE Ratio
4.93
Forward PE
11.36
PEG Ratio
0.01
Forward PEG
-0.00
PS Ratio
0.87
Forward PS
0.60
PB Ratio
13.70
P/FCF Ratio
5.88
P/Adj. FCF Ratio
5.56
P/OCF Ratio
7.28
EV/Sales
0.82
EV/EBIT
2.00
EV/EBITDA
1.86
EV/FCF
5.53
Earnings Yield
20.3%
FCF Yield
17.0%
Adj. FCF Yield
18.0%

Financial Health

Net Cash
$2.25M
Total Debt
$7.13M
Cash & Short-Term Investments
$9.38M
Total Assets
$36.61M
Current Ratio
1.28
Quick Ratio
0.89
Debt / Equity Ratio
7.43
Debt / EBITDA
0.37
Debt / FCF
1.10
OCF / Debt
0.79
Interest Coverage
0.19
Altman Z-Score
-5.70
Piotroski F-Score
5

Margins & Profitability

Gross Profit Margin
75.2%
Operating Profit Margin
1.5%
EBITDA Margin
43.9%
Net Profit Margin
32.6%
FCF Margin
14.8%
Adj. FCF Margin
15.6%
SBC / Revenue
-4.5%
SBC Impact (per share)
-5.7%

Returns

Return on Assets
39.1%
Return on Equity
1728.1%
Return on Invested Capital
2.8%
Return on Capital Employed
3.7%
Return on Tangible Assets
54.1%

Historical Growth (CAGR)

Revenue CAGR 3Y
34.3%
Revenue CAGR 5Y
39.7%
Revenue CAGR 10Y
46.1%
EPS CAGR 3Y
51.5%
EPS CAGR 5Y
38.9%
EPS CAGR 10Y
15.5%
FCF CAGR 3Y
408.5%
FCF CAGR 5Y
119.5%
FCF CAGR 10Y
10.6%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
2
EPS Growth Next 3Y
-407.6%
Revenue Growth Next 3Y
-50.9%
Earnings Date
Nov 5, 2026
EPS Estimate (next Q)
$0.01
EPS Growth Est (next Q)
-97.8%
Revenue Est (next Q)
$13.75M
Revenue Growth Est (next Q)
20.1%

Fair Value Estimates

Graham Number
$2.55
Graham Upside
-42.6%
Lynch Fair Value
$22.50
Lynch Upside
406.8%
Price Target
$54
Price Target Upside
1116.2%

Cash Flow

Operating Cash Flow
$5.62M
Free Cash Flow
$6.49M
Adj. Free Cash Flow
$6.86M
FCF Per Share
$0.72
OCF Per Share
$0.61
OCF/S Ratio
11.9%

Income Statement

Revenue
$43.9M
Gross Profit
$33.01M
Operating Income
$678K
EBITDA
$19.28M
Net Income
$14.31M
EPS (Diluted)
$0.90
Revenue / Employee
$798.24K
Profit / Employee
$260.24K
Employees
55

© 2026 bestshares.com. All rights reserved.